WISC Partners

Rehabpulse is revolutionizing the access to medical products that enhance people's lives. The company was founded in 2019 and is headquartered in Middleton, Wisconsin.

Wellbe develops a cloud-based platform that facilitates connected care between patients and healthcare providers. It empowers patients to participate as active partners in their treatment and giving providers the ability to monitor large numbers of patients more effectively.

Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, and ideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management.

PegEx, Inc. is an environmental technology company that serves the waste management industry. The cloud based software is suited for waste generators, brokers, haulers, and disposal facilities. PegEx's easy to use software that improves profitability, efficiencies and compliance of your entire waste operation. Anytime. Anywhere.

Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, and ideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management.

Wellbe develops a cloud-based platform that facilitates connected care between patients and healthcare providers. It empowers patients to participate as active partners in their treatment and giving providers the ability to monitor large numbers of patients more effectively.

Murfie is an online platform for buying, selling, and trading music collections with remote storage and digital access. The company offers a buying, selling, and trading community for music lovers who want traditional ownership with the convenience of remote storage and digital access. It was founded in 2010 and is headquartered in Madison, Wisconsin.

Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, and ideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management.

Murfie is an online platform for buying, selling, and trading music collections with remote storage and digital access. The company offers a buying, selling, and trading community for music lovers who want traditional ownership with the convenience of remote storage and digital access. It was founded in 2010 and is headquartered in Madison, Wisconsin.

Wellbe develops a cloud-based platform that facilitates connected care between patients and healthcare providers. It empowers patients to participate as active partners in their treatment and giving providers the ability to monitor large numbers of patients more effectively.

Rowheels features a durable medical equipment market with a revolutionary propulsion system for manual wheelchairs. Its mission is to make the standard wheelchair wheel obsolete and Rowheels the norm! We understand that this won’t be easy but pushing propulsion is inefficient, uses poor biomechanics, and is a major cause of shoulder injury and pain.

SafeLumin provides instant and safe backup lighting during a power outage. The company focuses on bringing into the home the same emergency lighting options as seen in commercial buildings during power outages or natural disasters morphed into the Safelumin light bulb. In 2015 Safelumin was incorporated as a separate company solely focused on consumer emergency lighting solutions.

Rowheels features a durable medical equipment market with a revolutionary propulsion system for manual wheelchairs. Its mission is to make the standard wheelchair wheel obsolete and Rowheels the norm! We understand that this won’t be easy but pushing propulsion is inefficient, uses poor biomechanics, and is a major cause of shoulder injury and pain.

Wellbe develops a cloud-based platform that facilitates connected care between patients and healthcare providers. It empowers patients to participate as active partners in their treatment and giving providers the ability to monitor large numbers of patients more effectively.

Rowheels features a durable medical equipment market with a revolutionary propulsion system for manual wheelchairs. Its mission is to make the standard wheelchair wheel obsolete and Rowheels the norm! We understand that this won’t be easy but pushing propulsion is inefficient, uses poor biomechanics, and is a major cause of shoulder injury and pain.

Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, and ideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management.